Skip to main content
OpenTrials
Completed

NCT Number: NCT04333446

Circulating Levels of Pealbumin in Relation to Overweight or Obesity

The study was aimed to investigating the relationship between circulating level of prealbumin and parathormone (PTH), triglycerides and triiodothyronine (FT3) in overweight and obese subjects (BMI≥25 Kg/m2)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

Luisa Lampignano

Castellana Grotte, 70013, Italy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Overweight or obesity (BMI> 25 Kg/m2)

Exclusion criteria

  • Any kind of drug Hypertension Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), Chronic inflammatory diseases Renal failure Liver failure Angina pectoris Myocardial infarction and heart failure Genetic heart diseases Thrombocytopenias

Treatment and study plan

Primary outcomes

  1. Prealbumin

    Time frame: baseline

    Prealbumin (g/L) concentration in serum

  2. Free Triiodothyronine (FT3)

    Time frame: baseline

    FT3 (pg/mL) concentration in serum

  3. Parathormone (PTH)

    Time frame: baseline

    PTH (pg/mL) concentration in serum

  4. Triglycerides

    Time frame: baseline

    Triglycerides (mg/dl) concentration in serum

Secondary outcomes

  1. Height

    Time frame: baseline

    Height in meters

  2. Weight

    Time frame: baseline

    Weight in kilograms

  3. Body mass Index (BMI)

    Time frame: baseline

    BMI (kg/m^2)

Sponsors and collaborators

Lead sponsor

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Other

Registry information

Official study title

Independent Relationship Between Prealbumin and Circulating Levels of Parathormone Triglycerides and FT3 in Subjects With Overweight or Obesity

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Apr 3, 2020
Registry last updated
May 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.